PDF of Trial CTRI Website URL - http://ctri.nic.in Clinical Trial Details (PDF Generation Date :- Thu, 23 Sep 2021 22:25:14 GMT) CTRI Number CTRI/2014/09/005042 [Registered on: 22/09/2014] - Trial Registered Prospectively Last Modified On 06/10/2015 Post Graduate Thesis No Type of Trial Interventional Type of Study Biological Study Design Randomized, Parallel Group, Active Controlled Trial Public Title of Study A Phase III study to compare the safety and efficacy of Bevacizumab against Avastin™ in Patients with Non-Small Cell Lung Cancer Scientific Title of A Prospective, Comparative, Open Label, Randomized, Multicentric, Phase III study to compare the Study safety and efficacy of Bevacizumab of Intas Pharmaceuticals Limited against Avastin™ in Patients with Unresectable or Metastatic Non-Squamous Non-Small Cell Lung Cancer Secondary IDs if Any Secondary ID Identifier 476-13; Version 02; 10 Mar 14 Protocol Number Details of Principal Details of Principal Investigator Investigator or overall Name Harshit Shah Trial Coordinator (multi-center study) Designation Ass.Project Manager Affiliation Lambda Therapeutic Research Ltd Address Lambda Therapeutic Research Ltd, Plot No. 38, Near Silver Oak Club, S.G. Highway, Gota Ahmadabad GUJARAT 380061 India Phone 07940202067 Fax 07940202021 Email
[email protected] Details Contact Details Contact Person (Scientific Query) Person (Scientific Name Dr Arpit Prajapati Query) Designation Manager Affiliation Lambda Therapeutic Research Ltd Address Lambda Therapeutic Research Ltd, Plot No. 38, Near Silver Oak Club, S.G. Highway, Gota Ahmadabad GUJARAT 380061 India Phone 07940202322 Fax 07940202021 Email
[email protected] Details Contact Details Contact Person (Public Query) Person (Public Query) Name Harshit Shah Designation Ass.Project Manager Affiliation Lambda Therapeutic Research Ltd Address Lambda Therapeutic Research Ltd, Plot No.